Nav: Home

Current Lung cancer News and Events

Current Lung cancer News and Events, Lung cancer News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Study reveals disparities in access to high-quality surgical care
Among U.S. patients diagnosed with breast, prostate, lung, or colorectal cancer from 2004 to 2016, those who were uninsured or had Medicare or Medicaid were less likely than privately insured patients to receive surgical care at high-volume hospitals. (2020-10-21)
Cholesterol medications linked to lower cancer-related deaths in women
Among women with breast cancer, colorectal cancer, or melanoma, those who were taking cholesterol-lowering medications, were less likely to die from cancer, according to an analysis published in the British Journal of Clinical Pharmacology. (2020-10-21)
Aggressive melanoma cells at edge of tumours are key to cancer spread
Research led by Queen Mary University of London has revealed novel insights into the mechanisms employed by melanoma cells to form tumours at secondary sites around the body. (2020-10-20)
The road to uncovering a novel mechanism for disposing of misfolded proteins
The discovery of the cause of a rare liver disease in babies led to uncovering a novel cellular mechanism for disposing of misfolded proteins that has implications for neurodegenerative conditions of older age (2020-10-20)
CNIO team finds how melanoma 'deceives' the immune system, increasing resistance to immunotherapy
* The CNIO researchers have identified how melanoma redirects the immune system, preventing it from attacking the tumour and transforming it into an ally in cancer development * A key element in this 'deception' is MIDKINE, a protein that modifies the function of several components of the immune system. (2020-10-19)
Rutgers finds new way to personalize treatments for prostate cancer
Rutgers researchers have discovered human gene markers that work together to cause metastatic prostate cancer - cancer that spreads beyond the prostate. (2020-10-19)
Less invasive ventilation use grows dramatically, without needed data
Analysis of nearly 2.5 million Medicare-funded hospitalizations near the end of a patient's life found the use of non-invasive ventilation has increased substantially, even though there is little data to support its use in certain patient groups, such as those with cancer and dementia near the end of life. (2020-10-19)
Novel mechanical mechanism of metastatic cancer cells in substrates of different stiffness revealed
Metastasis, the spread of cancer cells to a different body part from where it started, is considered as the most dangerous phase of cancer development. (2020-10-16)
Moffitt researchers develop tool to better predict treatment course for lung cancer
In a new article published in Nature Communications, Moffitt Cancer Center researchers demonstrate how a deep learning model using positron emission tomography/computerized tomography radiomics can identify which non-small cell lung cancer patients may be sensitive to tyrosine kinase inhibitor treatment and those who would benefit from immune checkpoint inhibitor therapy. (2020-10-16)
Oncotarget: Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance
Oncotarget Volume 11, Issue 29 reported that Immunosuppressive chemoresistance is a major burden in lung cancer. (2020-10-15)
Moffitt researchers discover specific molecules that promote cancer progression
In a new article published in the journal Nature Communications, Moffitt Cancer Center researchers describe how the protein TAp63 controls levels of RNA molecules, which subsequently connects the activities of p53 and AKT to promote disease progression. (2020-10-15)
Ultrasound technique offers more precise, quantified assessments of lung health
Researchers have developed a technique that uses ultrasound to provide non-invasive assessments of pulmonary fibrosis and pulmonary edema. (2020-10-15)
Oncotarget: Efavirenz induces DNA damage response pathway in lung cancer
The cover for Issue 41 of Oncotarget features Figure 7, ''IPA ATM-signaling pathway in (A) EFV treated MRC-5 and (B) A549 cells,'' recently published in ''Efavirenz induces DNA damage response pathway in lung cancer'' by Marima, et al. which reported that the cell-cycle related genes are potential gene targets in understanding the effects of efavirenz in lung cancer. (2020-10-14)
Oncotarget: miR-708-5p targets oncogenic prostaglandin E2 production in lung cancer cell
Volume 11, Issue 26 of Oncotarget reported that Lung cancer is of particular importance, as it is the deadliest cancer worldwide. (2020-10-13)
Long-term, frequent phone counseling helps cancer patients who smoke quit
Recently diagnosed cancer patients who smoke are significantly more likely to quit and remain tobacco-free if they receive frequent and sustained telephone counseling, according to a new study. (2020-10-13)
Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks
In a major contribution to tumor gene testing for cancer treatment selection, a molecular study of 6000 patients in the NCI-MATCH precision medicine cancer trial has broad relevance/will guide future trials. (2020-10-13)
Depression/anxiety in mums-to-be linked to heightened asthma risk in their kids
Depression and anxiety in mums-to-be is linked to a heightened risk of asthma and poorer lung function in their 10 year old children, finds research published online in the journal Thorax. (2020-10-12)
Oncotarget: Rapid onset type 1 diabetes with anti-PD-1 directed therapy
Volume 11, Issue 28 of Oncotarget features 'Rapid onset type 1 diabetes with anti-PD-1 directed therapy', by Yun et al. and reported that Type 1 diabetes is a rare immune-related adverse event caused by checkpoint inhibitors with serious risk for diabetic ketoacidosis. (2020-10-09)
Pulmonary artery thrombosis a complication of radiation therapy
According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize. (2020-10-09)
The world's first successful identification and characterization of in vivo senescent cells
A research team led by Professor Makoto Nakanishi of the Institute of Medical Science, the University of Tokyo, generated a p16-Cre ERT2 -tdTomato mouse model to characterize in vivo p16 high cells at the single-cell level. (2020-10-07)
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
Kanazawa University researchers reported that the SUCLA2 gene is frequently involved in the deletion of the tumor suppressor gene RB1 in advanced prostate cancer. (2020-10-07)
Enhanced reimbursement to oncology clinics increases prescriptions of evidence-based drugs
A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology. (2020-10-07)
Study offers global review of impact of COVID-19 on cancer treatment and research
The report, by researchers at Dana-Farber Cancer Institute and other institutions, suggests that while COVID-19 has complicated the treatment of cancer patients, it has also spurred creative solutions to challenges in clinical care, and research into the new disease is benefiting from insights gained over years of cancer research. (2020-10-06)
Potential drug treatment for particular type of lung-cancer
Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib. (2020-10-05)
New tools improve care for cancers that spread to the brain
The UVA team says its findings will help doctors and patients make better-informed treatment decisions, enhance the care of brain metastases, and enable hospitals to improve the coordination and effectiveness of their interdisciplinary treatment programs. (2020-10-05)
Liquid biopsies timely and effective testing method for NSCLC patients in Canada
Next-generation sequencing (NGS) of cell-free DNA (cfDNA) obtained from blood samples may improve diagnostic testing in patients with advanced NSCLC, and may also be faster and less expensive compared to standard tissue profiling, according to research presented today at the IASLC 2020 Lung Cancer Hot Topic: Liquid Biopsy Virtual Conference. (2020-10-02)
Liquid biopsy faster than tissue biopsy, improves time to treat
A pilot study comparing the effects of a liquid biopsy with tissue-based test showed that liquid biopsy turn-around time for results was approximately 10 days faster than the tissue biopsy, according to research presented today at the IASLC 2020 Lung Cancer Hot Topic: Liquid Biopsy Virtual Conference. (2020-10-02)
Cancer immunotherapy 'uniquely suppressed' by liver tumors
Though cancer immunotherapy has become a promising standard-of-care treatment--and in some cases, perhaps a cure--for a wide variety of different cancers, it doesn't work for everyone, and researchers have increasingly turned their attention to understanding why. (2020-10-02)
Counties with persistent poverty rates experience higher rates of cancer deaths
Residents of counties that experience persistent poverty face a disproportionately high risk of cancer mortality. (2020-09-30)
Innate lymphoid cells regenerate within lung
Max Planck researcher Dominic Grün teamed up with colleagues from Würzburg headed by Georg Gasteiger and generated a comprehensive atlas of Innate lymphoid cells (ILCs) of the lung. (2020-09-30)
AI can detect COVID-19 in the lungs like a virtual physician, new study shows
A University of Central Florida researcher is part of a new study showing that artificial intelligence can be nearly as accurate as a physician in diagnosing COVID-19 in the lungs. (2020-09-30)
Cancer cells use nerve-cell tricks to spread from one organ to the next
New research suggests that breast and lung tumors metastasize by hijacking a neural signaling pathway, potentially opening the door to better diagnostics and treatments. (2020-09-30)
Oncotarget: NRXN1 as a novel potential target for small cell lung cancer
The cover for issue 39 of Oncotarget features Figure 4, ''Apoptosis assay of NRXN1-targeted ADC at IC50 dose calculated by growth inhibition curves,'' by Yotsumoto, et al. which reported that the authors identified transmembrane proteins overexpressed specifically in SCLC with little or no expression in normal tissues and decided to focus on the cell adhesion molecule neurexin-1. (2020-09-30)
Prostate cancer: immunotherapy offers hope
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. (2020-09-29)
Breast cancer medication risk
New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients. (2020-09-29)
Researchers create artificial lung to support pre-term babies in distress
An international team led by current and former McMaster University researchers has developed an artificial lung to support pre-term and other newborn babies in respiratory distress. (2020-09-29)
In deadly COVID-19 lung inflammation, BU researchers discover a culprit in NFkB
In Deadly COVID-19 Lung Inflammation, BU Researchers Discover a Culprit in NFkB Pathway.Team now searching for a therapeutic that could block NFkB from unleashing unchecked inflammation at the onset of coronavirus infection. (2020-09-29)
Landmark clinical trial shows effectiveness of oral antibiotics in treating cystic fibrosis condition
A major national study led by experts from Bristol and Nottingham has found that oral antibiotics are just as effective as intravenous antibiotics in killing a common germ that causes dangerous complications in cystic fibrosis (CF) patients. (2020-09-29)
Cancer's hidden vulnerabilities
To fight cancer more effectively, a Caltech researcher probes its inner workings for metabolic weaknesses. (2020-09-28)
Clinical trial of selpercatinib shows strong response for patients with non-small cell lung cancer
Drug shown to precisely target non-small cell lung cancer driven by mutations to gene RET. (2020-09-28)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Sound And Silence
Sound surrounds us, from cacophony even to silence. But depending on how we hear, the world can be a different auditory experience for each of us. This hour, TED speakers explore the science of sound. Guests on the show include NPR All Things Considered host Mary Louise Kelly, neuroscientist Jim Hudspeth, writer Rebecca Knill, and sound designer Dallas Taylor.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

Kittens Kick The Giggly Blue Robot All Summer
With the recent passing of Ruth Bader Ginsburg, there's been a lot of debate about how much power the Supreme Court should really have. We think of the Supreme Court justices as all-powerful beings, issuing momentous rulings from on high. But they haven't always been so, you know, supreme. On this episode, we go all the way back to the case that, in a lot of ways, started it all.  Support Radiolab by becoming a member today at Radiolab.org/donate.